Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of ...
The FDA expands approval of Skyrizi (risankizumab-rzaa) for pediatric patients aged 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis.
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient ...
From U.S. v. Virginia, decided yesterday by Judge Robert Payne (E.D. Va.); these conclusions played a role in the ...
ALBUQUERQUE, N.M. (KRQE) – They’re hard-to-miss, mysterious symbols, now blanketing a downtown wall. However, those symbols are meant to help people figure out where things are in downtown Albuquerque ...
RelabotulinumtoxinA is a liquid neuromodulator designed to deliver rapid clinical improvement in glabellar and lateral canthal lines.
The following is the full transcript of an interview with former CDC chief medical officer Dr. Debra Houry, a portion of which aired on "Face the Nation with Margaret Brennan" on July 5, 2026. This ...
Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.
We knew this was coming, Google Ads now allows you to upload your customer loyalty data, i.e. Customer Match data, via the ...
Several new laws go into effect in California on July 1. Here's what you need know about phone-free schools, gun regulation ...
Several new laws go into effect in California on July 1. Here's what you need know about food labels, streaming ads and more.
A multinational aerospace, defense, and security technology company has begun marketing an upgrade to its Automatic License Plate Reader (ALPR) system that records smart device identifiers — like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results